TECFIDERA

Type: Keyphrase
Name: TECFIDERA
First reported 6 hours ago - Updated 22 mins ago - 2 reports

Biogen Idec Suggests PML Risk Manageable For Tecfidera , After Reporting First Case

Legacy Cost: Takeda’s Entyvio Development Shaped By Tysabri Fallout Pharmaceutical Approvals Monthly October 2014With Tecfidera, Biogen Idec Delivers Best MS Product Launch Yet “The Pink Sheet” DAILY Jul. 25, 2013Rituxan Market Expansion In ... [Published Health News Daily - 22 mins ago]
First reported 14 hours ago - Updated 14 hours ago - 1 reports

Biogen Idec reports double-digit revenue growth in Q3 2014

:10 in Pharmaceutical Company Financials Biogen Idec has announced its financial results for the third quarter of 2014, during which it recorded a revenue total of $2.5 billion (1.56 billion pounds). This represented a 37 percent year-on-year increase, ... [Published Zenopa - 14 hours ago]
First reported 19 hours ago - Updated 19 hours ago - 1 reports

ClinicSpeak: PML and dimethyl fumarate (Tecfidera)

How should we deal with the PML risk in patients on Tecfidera? #ClinicSpeak #MSBlog #MSResearch "Apologies about using email as a tool to blog. I am currently at a meeting in Dubai and can't use  the normal blogger platform as Google has set it to ... [Published Multiple Sclerosis Research - 19 hours ago]
First reported Oct 23 2014 - Updated Oct 23 2014 - 8 reports

PML case reported for dimethyl fumarate (Tecfidera)

23 October 2014Author: MS TrustA case of PML (progressive multifocal leukoencephalopathy) has been reported in a person who had been taking dimethyl fumarate (Tecfidera).The person, who subsequently died of complications from pneumonia, had been taking ... [Published Multiple Sclerosis Trust - Oct 23 2014]
First reported Oct 22 2014 - Updated Oct 23 2014 - 2 reports

Wall Street rally comes to sharp halt

US stocks fell at the close, snapping a three-day rally for the Dow that lifted the benchmark from six-month lows.At the closing bell, the Dow Jones Industrial Average declined 153 points, or 0.9 per cent, to 16,461.The S&P 500 declined 14 points, or ... [Published Business Spectator - Oct 22 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

US stocks ends lower

:41:35 A A- A+ US stocks erased earlier gains to close lower on Wednesday as a shooting at the Canadian parliament unnerved investors, Boeing and Biogen sold off following results, and energy stocks fell along with oil prices. The Dow Jones industrial ... [Published Financial Express Bangladesh - Oct 23 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

US stocks drop as winning streak ends

New York - US stocks dropped on Wednesday following mixed earnings as the market retreated after three straight sessions of big gains.At the closing bell, the Dow Jones Industrial Average stood at 16 465.11, down 149.70 points (0.90%).The broad-based ... [Published News24 - Oct 23 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Falling oil price and sell offs hit Wall St run

US STOCKS erased earlier gains yesterday to close lower as a shooting at the Canadian parliament unnerved investors, Boeing and Biogen Idec sold off following results and energy company shares fell along with oil prices.The Dow Jones industrial average ... [Published City A.M. - Oct 23 2014]
First reported Oct 22 2014 - Updated Oct 23 2014 - 4 reports

Wall St. lower after shooting at Canadian parliament

"If markets can connect the dots that this is a wider-ranging concern on domestic terrorism, it'll put weight on the markets along with global growth," said John Canally, chief economic and investment strategist for LPL Financial. Biogen Idec (BIIB.O) ... [Published Yahoo! Finance UK and Ireland - Oct 22 2014]
First reported Oct 22 2014 - Updated Oct 22 2014 - 25 reports

Biogen Idec reports death of patient that had taken its multiple sclerosis pill Tecfidera

Biogen Idec Inc. said Wednesday that a patient who had taken its multiple sclerosis pill Tecfidera for more than four years died after getting a rare brain infection, sending shares of the Cambridge biotechnology company falling on the Nasdaq stock e ... [Published Boston Globe - Oct 22 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

3 Stocks That Could Surprise This Earnings Season

Rising industry trends, new products, competitor pricing, and any number of other things can cause share prices to pop or drop during earnings season. That makes this time of year particularly perilous, so we asked three of our top analysts to crunch ... [Published Motley Fool - Oct 21 2014]
First reported Oct 20 2014 - Updated Oct 21 2014 - 3 reports

Forward Pharma's Threat To Biogen Idec's Tecfidera

Related Biotechnology, Pharmaceutical and Healthcare NewsOriginal Article: NEXT ARTICLE More From BioPortfolio on "Forward Pharma's Threat To Biogen Idec's Tecfidera" Search BioPortfolio:Loading ... [Published BioPortfolio - Oct 20 2014]

Quotes

...Dr George Scangos, chief executive officer of Biogen Idec, said: "The third quarter was a period of significant achievement as we continued to make progress against our corporate objectives."
We will also need to be more vigilant about screening for lymphopenia in patients on DMF. The EMA summary of product characteristics states: "Tecfidera may decrease lymphocyte counts (see section 4.8). Tecfidera has not been studied in patients with pre-existing low lymphocyte counts and caution should be exercised when treating these patients. Prior to initiating treatment with Tecfidera, a recent complete blood count (i e. within 6 months) should be available.  Assessments of complete blood counts are also recommended after 6 months of treatment and every 6 to 12 months thereafter and as clinically indicated" . I would suggest that we now institute 6 monthly monitoring as we do for patients on interferon-beta
"After a pretty big S&P rally, at some point there was going to be some pause" said Michael James, managing director of equity trading at Wedbush Securities
3D Systems Corp. ( DDD ) warned of a third-quarter revenue shortfall, citing "the continued manufacturing capacity constraints for its direct-metals printers and delayed availability of its newest consumer products." Shares sank 14.7% to $37 premarket

More Content

All (170) | News (131) | Reports (1) | Blogs (38) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Biogen Idec Suggests PML Risk Manageable For Te... [Published Health News Daily - 22 mins ago]
Biogen Falls on Concerns Regarding Tecfidera Sa... [Published Yahoo! Finance - 6 hours ago]
East Coast Biotech Roundup: PureTech, Celgene, ... [Published Xconomy - 13 hours ago]
Biogen Idec reports double-digit revenue growth... [Published Zenopa - 14 hours ago]
ClinicSpeak: PML and dimethyl fumarate (Tecfidera) [Published Multiple Sclerosis Research - 19 hours ago]
PML case reported for dimethyl fumarate (Tecfid... [Published Multiple Sclerosis Trust - Oct 23 2014]
Fidelity Biotech Fund Cut Biogen Stake Over Fiv... [Published Bloomberg - Oct 23 2014]
BUZZ-U.S. Stocks on the Move-3M, AT&T, Caterpil... [Published London South East - Oct 23 2014]
Case of PML confirmed in someone taking Tecfidera [Published Noodls - Oct 23 2014]
Stock Market News for October 23, 2014 [Published Yahoo! Finance - Oct 23 2014]
Biogen Falls On Patient’s Death [Published Bidness Etc - Oct 23 2014]
Biogen Idec third-qtr net rockets 76% but share... [Published Pharma Letter - Oct 23 2014]
Bad News as first PML case appears to be linked... [Published Multiple Sclerosis Research - Oct 23 2014]
Case of PML confirmed in someone taking Tecfidera [Published MS News - Oct 23 2014]
US stocks ends lower [Published Financial Express Bangladesh - Oct 23 2014]
US stocks drop as winning streak ends [Published News24 - Oct 23 2014]
U.S. Hot Stocks: Hot Stocks to Watch [Published TD Ameritrade - Oct 23 2014]
Biogen Idec Slumps After Patient On Top-Selling... [Published BioSpace - Oct 23 2014]
Falling oil price and sell offs hit Wall St run [Published City A.M. - Oct 23 2014]
Biogen stock hurt by Tecfidera rare brain infec... [Published Pharma Times - Oct 22 2014]
Biogen Idec inc Earnings Were Great. Here's Why... [Published Motley Fool Discussion Boards - Oct 22 2014]
Why Boeing Co, Biogen Idec Inc, and Discover Fi... [Published InvestorPlace.com - Oct 22 2014]
Active Stocks: Amgen, Alkermes, Nanosphere, Bio... [Published BioMedReports - Oct 22 2014]
Biogen Falls After Patient Taking Top-Selling T... [Published Washington Post - Oct 22 2014]
US stocks drop after days of big gains (AFP) [Published West Australian - Oct 22 2014]
Global shares falter as Wall Street tumbles; bo... [Published Yahoo! News UK and Ireland - Oct 22 2014]
The close: Markets fall as slumping oil weighs ... [Published Globe and Mail - Oct 22 2014]
Wall Street rally comes to sharp halt [Published Business Spectator - Oct 22 2014]
Wall Street rally comes to halt [Published Business Spectator - Oct 22 2014]
U.S. Stocks Decline Amid Price Data as Oil Tumb... [Published Washington Post - Oct 22 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ClinicSpeak: PML and dimethyl fumarate (Tecfidera) [Published Multiple Sclerosis Research - 19 hours ago]
How should we deal with the PML risk in patients on Tecfidera? #ClinicSpeak #MSBlog #MSResearch "Apologies about using email as a tool to blog. I am currently at a meeting in Dubai and can't use  the normal blogger platform as Google has set it to ...
Bad News as first PML case appears to be linked... [Published Multiple Sclerosis Research - Oct 23 2014]
#MSResearch PML case associated with Tecfidera/BG-12 With every new hope in MS there appears to be a dash to break that hope and news just coming in from Reuters  suggests that there has apparently been a case of PML with Tecfidera, which was announced ...
Case of PML confirmed in someone taking Tecfidera [Published MS News - Oct 23 2014]
Biogen Idec have confirmed that a patient taking the drug Tecfidera (dimethyl fumarate) has contracted the rare brain infection progressive multifocal leukoencephalopathy ( PML ), and has recently died as a result of complications from pneumonia. ...
New to ms [Published HealthBoards - Oct 22 2014]
I found this board a few weeks ago and have learned so much since then. Thank you!I began experiencing numbness from the waist down on July 14th. The numbness was very prevalent in my feet...toes/balls of my feet. Walking was VERY uncomfortable and still ...
Can BG-12 affect remyelination? [Published Multiple Sclerosis Research - Oct 05 2014]
#MS Research Can #Tecfidera affect #remyelination Arnold DL, Gold R, Kappos L, Bar-Or A, Giovannoni G, Selmaj K, Yang M, Zhang R, Stephan M, Sheikh SI, Dawson KT.  Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.  J ...
1 2 3 4 5 6 7 8
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.